BACKGROUND: Management of dual antiplatelet therapy (DAPT) in the perioperative setting is challenging, particularly in complex patient populations, such as those with underlying coagulopathy and/or recent percutaneous coronary interventions.

METHODS: In this case series, we describe the perioperative use of cangrelor bridge therapy in two patients undergoing liver transplantation after recent coronary drug-eluting stent placement.

OUTCOMES: In both patient cases, cangrelor use as a P2Y12 bridge at a dose of 0.75 mcg/kg/min was safe and effective. Both patients were successfully switched back to their oral DAPT regimen post-operatively without additive bleeding or thrombotic complications.

CONCLUSION: The use of cangrelor as bridge therapy in high-risk perioperative liver transplant patients appears to be a viable option when DAPT is warranted.

Original languageEnglish (US)
StateE-pub ahead of print - Jan 25 2022


Dive into the research topics of 'Perioperative Cangrelor in Patients with Recent Percutaneous Coronary Intervention Undergoing Liver Transplantation: A Case Series'. Together they form a unique fingerprint.

Cite this